BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Clinical Outcome
23 results:

  • 1. Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
    Khazaei S; Nilsson L; Adrian G; Tryggvadottir H; Konradsson E; Borgquist S; Isaksson K; Ceberg C; Jernström H
    Oncotarget; 2022; 13():439-453. PubMed ID: 35222809
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Endoscopic assisted breast conserving surgery for breast cancer: clinical outcome, learning curve, and patient reported aesthetic results from preliminary 100 procedures.
    Lai HW; Mok CW; Chang YT; Chen DR; Kuo SJ; Chen ST
    Eur J Surg Oncol; 2020 Aug; 46(8):1446-1455. PubMed ID: 32115333
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy.
    Sanchez-Spitman AB; Dezentjé VO; Swen JJ; Moes DJAR; Gelderblom H; Guchelaar HJ
    Breast Cancer Res Treat; 2018 Nov; 172(2):401-411. PubMed ID: 30120701
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.
    Goncalves R; DeSchryver K; Ma C; Tao Y; Hoog J; Cheang M; Crouch E; Dahiya N; Sanati S; Barnes M; Sarian LOZ; Olson J; Allred DC; Ellis MJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):355-364. PubMed ID: 28612227
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Vacuum-assisted breast biopsies (VAB) carried out on an open 1.0T MR imager: Influence of patient and target characteristics on the procedural and clinical results.
    Krug B; Hellmich M; Ulhaas A; Krämer S; Rhiem K; Zarghooni V; Püsken M; Schwabe H; Grinstein O; Markiefka B; Maintz D
    Eur J Radiol; 2016 Jun; 85(6):1157-66. PubMed ID: 27161066
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single-stage breast reconstruction using Strattice™: A retrospective study.
    Dikmans RE; El Morabit F; Ottenhof MJ; Tuinder SM; Twisk JW; Moues C; Bouman MB; Mullender MG
    J Plast Reconstr Aesthet Surg; 2016 Feb; 69(2):227-33. PubMed ID: 26723835
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
    Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
    Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
    Qin X; Yao W; Li W; Feng X; Huo X; Yang S; Zhao H; Gu X
    Tumour Biol; 2014 May; 35(5):4697-704. PubMed ID: 24443257
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Network Oncology (NO)--a clinical cancer register for health services research and the evaluation of integrative therapeutic interventions in anthroposophic medicine.
    Schad F; Axtner J; Happe A; Breitkreuz T; Paxino C; Gutsch J; Matthes B; Debus M; Kröz M; Spahn G; Riess H; von Laue HB; Matthes H
    Forsch Komplementmed; 2013; 20(5):353-60. PubMed ID: 24200825
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine.
    Dong N; Yu J; Wang C; Zheng X; Wang Z; Di L; Song G; Zhu B; Che L; Jia J; Jiang H; Zhou X; Wang X; Ren J
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1197-203. PubMed ID: 22426923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.
    Shi H; Bevier M; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Feb; 131(3):1039-47. PubMed ID: 22037783
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.
    Shi H; Bevier M; Johansson R; Grzybowska E; Chen B; Eyfjörd JE; Hamann U; Manjer J; Enquist K; Henriksson R; Carlson J; Brandt A; Lascorz J; Butkiewicz D; Pamula-Pilat J; Tecza K; Herms S; Hoffmann P; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2011 Dec; 130(3):905-16. PubMed ID: 21630024
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen.
    Abraham JE; Maranian MJ; Driver KE; Platte R; Kalmyrzaev B; Baynes C; Luccarini C; Shah M; Ingle S; Greenberg D; Earl HM; Dunning AM; Pharoah PD; Caldas C
    Breast Cancer Res; 2010; 12(4):R64. PubMed ID: 20731819
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intraoperative bone marrow puncture in breast cancer patients: prospective assessment of adverse side-effects.
    Domschke C; Neubrech F; Dick M; Rom J; Beckhove P; Sohn C; Schuetz F; Scharf A
    Breast; 2011 Feb; 20(1):62-5. PubMed ID: 20621481
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multimodal approach to the management of metastatic epidural spinal cord compression (MESCC) due to solid tumors.
    Tancioni F; Navarria P; Lorenzetti MA; Pedrazzoli P; Masci G; Mancosu P; Alloisio M; Morenghi E; Santoro A; Rodriguez y Baena R; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1467-73. PubMed ID: 20231072
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.